Genotype-Phenotype diversity of Beta-Thalassemia in Malaysia: treatment options and emerging therapies

Elizabeth, G. and Ann, T.J.A.M. (2010) Genotype-Phenotype diversity of Beta-Thalassemia in Malaysia: treatment options and emerging therapies. Medical Journal of Malaysia, 65 (4). ISSN 0300-5283,

[img]
Preview
PDF
Genotype-phenotype_diversity_of_beta-thalassaemia.pdf - Published Version

Download (181kB)

Abstract

The haemoglobinopathies and thalassemias represent the most common inherited monogenic disorders in the world. Beta-thalassaemia major is an ongoing public health problem in Malaysia. Prior to 2004, the country had no national policy for screening and registry for thalassemia. In the absence of a national audit, the true figure of the extent of thalassemia in the Malaysian population was largely presumptive from micro-mapping studies from various research workers in the country. The estimated carrier rate for beta-thalassemia in Malaysia is 3.5-4. There were 4768 transfusion dependent thalassemia major patients as of May 2010 (Data from National Thalassemia Registry).

Item Type: Article
Funders: UNSPECIFIED
Additional Information: Department of Molecular Medicine, Faculty of Medicine, Unieversity of Malaya, 50603, Kuala Lumpur
Uncontrolled Keywords: Genotype-phenotype thalassemia Malaysia treatment options
Subjects: R Medicine
Divisions: Faculty of Medicine
Depositing User: Ms Haslinda Lahuddin
Date Deposited: 02 Oct 2012 02:07
Last Modified: 28 Feb 2019 09:12
URI: http://eprints.um.edu.my/id/eprint/3710

Actions (login required)

View Item View Item